Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Nov 8;13:1054143. doi: 10.3389/fphar.2022.1054143

Corrigendum: An integrative serum pharmacology-based approach to study the anti-tumor activity of B. Paniculatum aqueous bulb extract on the human hepatocellular carcinoma cell line BEL-7404

Xuesong Feng 1, Guangyuan Ma 1, Hailong Shi 1, Yuewen Wang 1, Xu Chao 1,2,*
PMCID: PMC9680086  PMID: 36425573

In the published article, there was an error in the Funding statement. We missed to include the funding support from the Education Department of Shaanxi Provincial Government of China (20JK0588). The correct Funding statement appears below.

“This study was supported by the fund from the Subject Innovation Team of Shaanxi University of Chinese Medicine (2019YS05), the Basic Scientific Research Project of Shaanxi Province (2020JQ-867) and the Education Department of Shaanxi Provincial Government of China (20JK0588)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES